Patents by Inventor Erica Brook Goodhew

Erica Brook Goodhew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF INDUCING NEGATIVE CHEMOTAXIS
    Publication number: 20140031321
    Abstract: The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of idebenone, benazepril, rolipram, moxonidine, lamivudine, loxoprofen, terbinafine, synephrine, 6-aminoindazole, and a Vitamin D analog, or a pharmaceutically acceptable salt of any of thereof.
    Type: Application
    Filed: January 14, 2013
    Publication date: January 30, 2014
    Applicant: CELTAXSYS, INC.
    Inventor: Erica Brook Goodhew
  • Method of inducing negative chemotaxis
    Patent number: 8377914
    Abstract: The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of idebenone, benazepril, rolipram, moxonidine, lamivudine, loxoprofen, terbinafine, Synephrine, 6-aminoindazole, and a Vitamin D analog, or a pharmaceutically acceptable salt of any of thereof.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: February 19, 2013
    Assignee: Celtaxsys, Inc.
    Inventor: Erica Brook Goodhew
  • METHOD OF INDUCING NEGATIVE CHEMOTAXIS
    Publication number: 20100093747
    Abstract: The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound having the Formula (I), (II), (III) or (IV).
    Type: Application
    Filed: October 9, 2009
    Publication date: April 15, 2010
    Inventor: Erica Brook Goodhew
  • METHOD OF INDUCING NEGATIVE CHEMOTAXIS
    Publication number: 20100093677
    Abstract: The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of idebenone, benazepril, rolipram, moxonidine, lamivudine, loxoprofen, terbinafine, Synephrine, 6-aminoindazole, and a Vitamin D analog, or a pharmaceutically acceptable salt of any of thereof.
    Type: Application
    Filed: October 9, 2009
    Publication date: April 15, 2010
    Inventor: Erica Brook Goodhew